Should You Get Kybella? Benefits, Risks & Alternatives

The useful question is not simply whether Kybella “works.” It does. The more important question is whether the fullness under your chin is actually the type of problem Kybella is designed to treat.

1. What Kybella Actually Treats

Kybella is the brand name for injectable deoxycholic acid. Deoxycholic acid disrupts fat-cell membranes, causing the treated adipocytes to be destroyed.

The FDA-approved indication is very specific: improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults.

In plain English, it is designed to reduce a double chin caused by fat directly beneath the chin.

That distinction matters because not every poorly defined jawline is a fat problem.

A fuller lower face or neck can also be influenced by:

• loose or descended skin
• platysmal bands
• a small or recessed chin
• deeper neck structures
• submandibular glands
• age-related tissue descent
• a combination of fat and skin laxity

Kybella cannot correct all of those causes.

If you are not sure what is creating the fullness, our double chin treatment guide compares the main nonsurgical and surgical approaches by anatomy rather than assuming everyone needs fat reduction.

2. Kybella Is Not Approved as a General Fat-Dissolving Injection

This point became even more important in September 2026.

The FDA updated Kybella’s prescribing information after reviewing adverse-event reports and medical literature involving injections outside the approved submental region. The revised label states that Kybella is not approved for subcutaneous fat outside the area beneath the chin and that such use is not recommended.

The FDA also issued a safety communication warning that serious neuromuscular and other adverse reactions have occurred after unapproved treatment outside the submental area.

3. Does Kybella Really Work?

Yes, in properly selected patients.

The FDA approval was supported by two large randomized, placebo-controlled U.S. trials involving adults with moderate or severe submental fullness.

Twelve weeks after the final treatment, a one-grade or greater improvement agreed upon by both clinician and patient was achieved by 70.0% of Kybella patients versus 18.6% of placebo patients in one trial, and by 66.5% versus 22.2% in the second.

MRI measurements provided an objective measure as well. Among the imaging subset, 43% of Kybella-treated participants had at least a 10% reduction in submental fat volume compared with 5% of placebo-treated participants.

A later systematic review and meta-analysis of randomized trials involving 1,838 participants also found that injectable deoxycholic acid produced greater improvement than placebo across several clinician-, patient- and imaging-based outcomes.

That does not mean every patient gets a dramatic change. The trials demonstrate an average treatment effect in selected patients. The amount of fat, skin quality, anatomy and treatment dose still matter.

4. Kybella Is Not Necessarily a One-Visit Treatment

The FDA label allows up to six Kybella treatment sessions, spaced at least one month apart.

That does not mean everyone requires six sessions. In the pivotal trials, 41% of participants received fewer than six treatments.

The appropriate number depends on:

• how much submental fat is present
• the size of the treatable area
• the amount used at each session
• how the patient responds
• the degree of change the patient wants

This is one reason comparing Kybella solely by a “price per session” can be misleading. Total treatment cost depends on the full plan.

For that topic, we keep pricing separate in our Kybella cost guide.

5. Swelling Is Part of the Treatment, Not a Rare Side Effect

Swelling is very common after Kybella. The current prescribing information lists injection-site swelling, bruising, pain, numbness, redness and firmness among the most common adverse reactions.

That swelling occurs because the treatment intentionally damages fat cells and produces a local inflammatory response while the tissue begins clearing them.

For many patients, the issue is less about being physically unable to work and more about how visible the swelling may be.

Patients planning treatment around weddings, photography, presentations or other important social events should leave enough recovery time rather than assuming an injectable means no visible downtime.

6. Kybella Has Important Risks Beyond Bruising

Kybella is a prescription medication administered in an anatomically sensitive area.

The current FDA label includes warnings for several important complications.

Marginal mandibular nerve injury

Injury to the marginal mandibular branch of the facial nerve can produce an asymmetric smile or facial muscle weakness. This is one reason precise injection location and depth matter.

Difficulty swallowing

Dysphagia has occurred after Kybella treatment. The label advises avoiding Kybella in patients with a current or previous history of swallowing difficulty because treatment may worsen the condition.

Skin ulceration and necrosis

Very superficial injection can result in skin ulceration and tissue necrosis. The updated label also addresses injection-site nodules, masses and infections, some of which may require medical treatment.

Temporary or persistent hair loss

Injection-site alopecia has been reported. The 2026 labeling specifically notes that its onset and duration vary and that it may persist.

Vascular injury and injury to nearby structures

The injection area contains nerves, vessels, salivary glands, lymph nodes and muscle. The FDA label stresses avoiding injections into or near vulnerable structures.

This is why choosing a provider based only on the lowest vial price is a poor way to evaluate Kybella treatment.

7. Who Is Actually a Good Kybella Candidate?

There is no evidence-based rule saying Kybella is ideal for men between one age range and women between another.

A stronger candidate generally has:

• a visible pocket of submental fat beneath the chin
• enough superficial fat to safely target
• reasonable skin elasticity
• realistic expectations about the amount of change
• a preference for nonsurgical treatment
• willingness to accept temporary swelling and possibly multiple sessions

Kybella is contraindicated if there is an infection in the injection area.

The label also calls for caution when bleeding risk is increased, including in patients taking antiplatelet or anticoagulant medication.

Previous facial or neck surgery, scar tissue, prior cosmetic treatments and altered anatomy should also be reviewed because they can affect treatment safety and the expected result.

Patients who are pregnant or planning pregnancy should tell their provider. The current label states that it is not known whether Kybella can harm an unborn baby.

8. Kybella Does Not Tighten Loose Skin

This is one of the most important candidacy questions.

If fat is reduced but the skin cannot redrape well, the neck can remain loose even though the fat pocket is smaller.

That does not make Kybella ineffective. It means the original diagnosis was incomplete if loose skin was a major part of the problem.

Depending on the anatomy, a provider may instead discuss or combine another approach aimed at skin laxity. Skin Works’ double chin and jawline guide compares Kybella with skin-tightening and surgical options.

Significant skin excess or deeper structural concerns may be better evaluated surgically rather than repeatedly adding nonsurgical treatments.

9. Kybella vs. Chin Liposuction: Which Makes More Sense?

Neither is automatically better. They solve the same fat concern in very different ways.

If pronounced fat is present and the patient wants a more immediate single-procedure change, a surgical consultation may be more efficient than a long injectable series.

Skin Works patients considering surgery can review chin liposuction at Adonis Plastic Surgery for a separate discussion of surgical candidacy, recovery and anatomy.

Are Kybella Results Permanent?

Kybella destroys the fat cells that are successfully treated. Those specific adipocytes do not regenerate in the usual sense.

But that should not be translated into “your neck can never become fuller again.”

Remaining fat cells can enlarge with future weight gain. Aging, skin laxity and changes in deeper neck anatomy can also alter the contour over time.

A more accurate description is that Kybella can produce long-lasting reduction of treated submental fat cells once the desired result has been achieved.

When Kybella Makes Sense, and When It Does Not

Frequently Asked Questions